ADIAL PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2017 to Q2 2024.
  • Adial Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$171K, a 427% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was -$114K, a 280% decline from 2022.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $63.3K.
  • Adial Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was -$229K, a 753% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$171K -$139K -427% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q4 2023 -$114K -$107K -$8.42K -8.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$106K $10.2K +$6.76K +195% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$112K -$32.5K -$39.4K -569% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$72.9K $14.9K -$136K -90.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $63.3K -$98.2K -$154K -275% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $218K $3.47K +$258K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$40K $6.93K +$44.1K Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-10-30
Q1 2022 -$84.1K $151K +$145K +2200% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$229K $56.2K +$54.9K +4067% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$284K -$254K -$257K -10142% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$26.8K -$37.2K -$44.9K -584% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $18.1K $6.57K -$16.9K -72% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $35K $1.35K -$31K -95.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $66K $2.53K -$27.3K -91.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $93.4K $7.68K -$16.9K -68.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $110K $23.4K +$457K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$347K $32.4K +$211K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$558K $29.9K +$4.4M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$4.96M $24.6K +$75.5K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$5.04M -$433K -$394K -999% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$4.64M -$179K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$4.37M -$4.34M -14381% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$50.9K -$28.1K -123% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$39.4K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 -$30.2K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$22.8K Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.